semaglutide sigma aldrich 30mg Research Peptide Semaglutide Acetate | 1997361-85-9
Description
Retatrutide (GLP3-R) 30mg research peptide is supplied as a high-purity synthetic multi-pathway peptide intended strictly for laboratory investigation of incretin receptor signaling and metabolic regulatory systems

A provider who specializes in obesity medicine can help determine whether tirzepatide is likely to work or whether other approaches, such as combination therapy, adding phentermine , or investigating underlying conditions, make more sense

Accessed May 2, 2025.

A characteristic feature is the loss of interstitial cells of Cajal, likely secondary to immunological changes, such as a shift from protective M2 to M1 macrophages and impaired regulation of haem oxygenase-1, leading to oxidative stress
Unlike exenatide which was based on exendin-4, semaglutide is based on the structure of human GLP-1 with specific modifications to improve its pharmacological properties

Like Ozempic, its often prescribed off-label for weight management, though the obesity-specific formulation (Zepbound) launched in late 2023
